HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $992,436 | +19.7% | 25,980 | +13.1% | 0.12% | +26.1% |
| Q2 2023 | $828,889 | -5.6% | 22,980 | 0.0% | 0.09% | -14.0% |
| Q1 2023 | $877,606 | -32.9% | 22,980 | 0.0% | 0.11% | -35.5% |
| Q4 2022 | $1,307,562 | -12.8% | 22,980 | -39.4% | 0.17% | -35.7% |
| Q3 2022 | $1,499,000 | -15.5% | 37,905 | -6.0% | 0.26% | -40.4% |
| Q2 2022 | $1,774,000 | -18.8% | 40,323 | -26.4% | 0.43% | -2.3% |
| Q1 2022 | $2,185,000 | -50.4% | 54,789 | -50.0% | 0.44% | -1.8% |
| Q4 2021 | $4,404,000 | +3977.8% | 109,530 | +4044.2% | 0.45% | +1779.2% |
| Q3 2021 | $108,000 | -78.2% | 2,643 | -85.7% | 0.02% | -81.0% |
| Q2 2020 | $496,000 | -43.8% | 18,495 | -79.3% | 0.13% | -42.7% |
| Q4 2016 | $883,000 | -18.2% | 89,388 | 0.0% | 0.22% | -18.5% |
| Q3 2016 | $1,080,000 | +40.1% | 89,388 | 0.0% | 0.27% | +28.0% |
| Q2 2016 | $771,000 | -36.1% | 89,388 | -29.8% | 0.21% | -34.7% |
| Q1 2016 | $1,206,000 | +1006.4% | 127,388 | +1922.0% | 0.32% | +1013.8% |
| Q4 2015 | $109,000 | -84.0% | 6,300 | -87.6% | 0.03% | -80.1% |
| Q3 2015 | $681,000 | -43.3% | 50,700 | -4.7% | 0.15% | -33.6% |
| Q2 2015 | $1,201,000 | – | 53,200 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |